Data for: "Lipid conjugation of TLR7 agonist Resiquimod ensures co-delivery with the liposomal Cationic Adjuvant Formulation 01 (CAF01) but does not enhance immunopotentiation compared to non-conjugated Resiquimod+CAF01"

Yvonne Perrie (Creator)

Strathclyde Institute Of Pharmacy And Biomedical Sciences

Dataset

1 Article

1 results

Filter

2018
Lipid conjugation of TLR7 agonist Resiquimod ensures co-delivery with the liposomal Cationic Adjuvant Formulation 01 (CAF01) but does not enhance immunopotentiation compared to non-conjugated Resiquimod+CAF01
Wilkinson, A., Lattmann, E., Roces, C. B., Pedersen, G. K., Christensen, D. & Perrie, Y., 10 Dec 2018, In: Journal of Controlled Release. 291, p. 1-10 10 p.
Research output: Contribution to journal › Article › peer-review

Open Access
File
20 Citations (Scopus)

24 Downloads (Pure)